SNY - Sanofi
47.13
-0.860 -1.825%
Share volume: 2,541,271
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$47.99
-0.86
-0.02%
Fundamental analysis
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Performance
5 Days
-1.94%
1 Month
0.36%
3 Months
0.36%
6 Months
0.36%
1 Year
0.36%
2 Year
0.36%
Key data
Stock price
$47.13
DAY RANGE
$47.08 - $47.76
52 WEEK RANGE
$46.06 - $48.59
52 WEEK CHANGE
$0.36
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Paul Hudson
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: sanofi.com
Employees: 91,600
IPO year: 2002
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation.
Recent news